Spire Healthcare Group (SPI) Trading Update summary

Trading performance and outlook

• Performance from January to April 2025 met expectations and aligns with 2025 guidance.

• Transformation programme targeting at least £30m in efficiencies for FY25 is progressing, with most benefits expected in H2.

• No material cost or supply chain impacts anticipated from recent tariff announcements due to full UK revenue exposure.

Strategic developments

• Named a founding supplier in the Government's National Strategic Supplier Relationship programme, strengthening NHS collaboration.

• Positioned for long-term, sustainable NHS commissioning growth.

Operational highlights

• Operates 38 hospitals and over 50 clinics, serving over 1 million patients in 2023.

• Leading private provider by volume for knee and hip operations in the UK.

• 98% of inspected locations rated 'Good' or 'Outstanding' by health inspectors.